Delivery Order SPE2DB22D1106-SPE2DB24FEBW7
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the delivery of TRULICITY 1.5 MG/0.5 ML PEN 0.5ML, a specialty pharmaceutical product, with a potential value of $13,933.44 and a completion date of March 1, 2024. Amerisourcebergen Drug Corp serves as the prime contractor for this order, which is part...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The delivery order, valued at $3,542.40, has an ultimate completion date of April 9, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary...
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract to provide TRULICITY 4.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has a potential value of $1,306.26 and a completion date of January 29, 2024. Amerisourcebergen Drug Corp is also the prime contractor on a $999,999,999.00 indefinite delivery contract (IDC) with DLA to deliver a comprehensive range of pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of TRULICITY 4.5 MG/0.5 ML PEN 0.5ML. The contract has a potential value of $1,306.26 and a completion date of February 2, 2024. Amerisourcebergen Drug Corp is the prime contractor, and no set-aside designation was used for this award. The contract is part of a larger indefinite...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The order, valued at $12,128.51, has a completion date of January 29, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, for the supply of TRULICITY 3 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract has a potential value of $1,741.68 and a completion date of February 22, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up to...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TRULICITY 3 MG/0.5 ML PEN 0.5ML pharmaceutical products. The $1,863.36 contract has a completion date of March 8, 2024. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December 2025 to deliver a comprehensive...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceuticals. The $5,805.60 award has a performance period ending on January 29, 2024. Amerisourcebergen Drug Corp is the prime contractor and there are no set-aside designations associated with this order. Amerisourcebergen Drug Corp is also the prime contractor on a larger...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TRULICITY 3 MG/0.5 ML PEN 0.5ML pharmaceutical products. The delivery order has a completion date of January 29, 2024 and a potential value of $4,354.20. This award is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, valued up to $999,999,999.00 through December 31, 2025, which...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of TRULICITY 0.75 mg/0.5 ml pens. The $7,965.65 contract has an ultimate completion date of April 2, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FEBW7Delivery Order
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TRULICITY 4.5 MG/0.5 ML PEN 0.5ML, a specialty pharmaceutical product. The award, valued at $12,168.31, has a completion date of February 27, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The delivery order awarded on February 26, 2024 is one of many firm fixed price task orders issued under this overarching IDC.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.2k | 2/26/24 |